Multiplex Assay Kit for Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay)

ADAMTS13; TTP; vWF-cp; vWF-cleaving protease; A Disintegrin And Metalloproteinase With A Thrombospondin Type 1 Motif Member 13

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-103 89
EDTA plasma(n=5) 80-93 89
heparin plasma(n=5) 79-91 87
sodium citrate plasma(n=5) 91-99 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-97% 98-105% 84-92% 97-105%
EDTA plasma(n=5) 82-101% 85-93% 87-95% 99-105%
heparin plasma(n=5) 89-96% 89-96% 83-101% 90-97%
sodium citrate plasma(n=5) 98-105% 85-99% 81-96% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:vWFCP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
33 Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney. pubmed:28139439
Experimental and Therapeutic Medicine Risk stratification and prognostic evaluation of endothelial cell‑specific molecule1, von Willebrand factor, and a disintegrin‑like and metalloprotease with …
Scientific Reports Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea Pubmed: 31882827
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA950Hu01 Recombinant Von Willebrand Factor Cleaving Protease (vWFCP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA950Hu02 Recombinant Von Willebrand Factor Cleaving Protease (vWFCP) Positive Control; Immunogen; SDS-PAGE; WB.
PAA950Hu02 Polyclonal Antibody to Von Willebrand Factor Cleaving Protease (vWFCP) WB; IHC; ICC; IP.
PAA950Hu01 Polyclonal Antibody to Von Willebrand Factor Cleaving Protease (vWFCP) WB; IHC; ICC; IP.
MAA950Hu22 Monoclonal Antibody to Von Willebrand Factor Cleaving Protease (vWFCP) WB; IHC; ICC; IP.
SEA950Hu ELISA Kit for Von Willebrand Factor Cleaving Protease (vWFCP) Enzyme-linked immunosorbent assay for Antigen Detection.
AEA950Hu ELISA Kit for Anti-Von Willebrand Factor Cleaving Protease Antibody (Anti-vWFCP) Enzyme-linked immunosorbent assay for Antibody Detection.
LMA950Hu Multiplex Assay Kit for Von Willebrand Factor Cleaving Protease (vWFCP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.